Home/Mesintel Therapeutics/R. Wilder Scott, PhD

RW

R. Wilder Scott, PhD

Chief Technology Officer

Mesintel Therapeutics

Therapeutic Areas

Oncology Fibrosis Rare Diseases Regenerative Medicine Aging

Leadership Team at Mesintel Therapeutics

T. Michael Underhill, PhD

Chief Executive Officer & Chief Scientific Officer

Lesley Hill, PhD

Chief Operating Officer

Jonathon Jafari, M.Sc MBA

Chief Business Officer

View full Mesintel Therapeutics profile